| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2168.2002.02151.X |
| P698 | PubMed publication ID | 12153626 |
| P2093 | author name string | Rutqvist LE | |
| Cedermark B | |||
| Johansson H | |||
| Holm T | |||
| Martling A | |||
| P2860 | cites work | Pancreas cancer resection outcome in American University centers in 1989-1990. | Q30466296 |
| Hospital caseload and the results achieved in patients with rectal cancer. | Q34093049 | ||
| Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival | Q34585222 | ||
| Mesorectal excision for rectal cancer | Q34726877 | ||
| Potency, cure, and local control in the operative treatment of rectal cancer | Q35283167 | ||
| Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project | Q39545521 | ||
| Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy | Q40816825 | ||
| Costs, quality, and the volume of surgical oncology procedures | Q41193358 | ||
| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. | Q44045712 | ||
| The importance of volume in colorectal cancer surgery | Q44189566 | ||
| Recurrence and survival after total mesorectal excision for rectal cancer | Q44519873 | ||
| Surgeon-related factors and outcome in rectal cancer | Q47769261 | ||
| The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. | Q50759541 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1008-1013 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | British Journal of Surgery | Q4970212 |
| P1476 | title | The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. | |
| P478 | volume | 89 |
| Q35760244 | A cross-specialty survey to assess the application of risk stratified surgery for differentiated thyroid cancer in the UK. |
| Q36343813 | A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design. |
| Q34985904 | A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design |
| Q36791079 | Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence |
| Q44847154 | Blood loss and transfusion after total mesorectal excision and conventional rectal cancer surgery. |
| Q63367375 | Cancérologie digestive : pratiques chirurgicales |
| Q37356964 | Case report: Locoregional (perineum and inguinal) recurrence after treatment of rectal cancer by low anterior resection |
| Q38211316 | Clinical competence in the surgery of rectal cancer: the Italian Consensus Conference. |
| Q35904488 | Colon cancer: survival after curative surgery. |
| Q36968408 | Colorectal cancer management in the provincial New Zealand setting of Nelson |
| Q39739040 | Correlation between County-Level Surgeon Density and Mortality from Colorectal Cancer |
| Q56441469 | Defining the surgical planes on MRI improves surgery for cancer of the low rectum |
| Q36241935 | Development and progression of colorectal neoplasia |
| Q37854498 | Does total mesorectal excision require a learning curve? Analysis from the database of a single surgeon's experience |
| Q50753133 | Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level. |
| Q39263752 | Evolution of Surgical Treatment for Rectal Cancer: a Review. |
| Q30485696 | Hospital factors and patient characteristics in the treatment of colorectal cancer: a population based study |
| Q50579299 | Hospital volume and outcome of rectal cancer surgery in Denmark 1994-99. |
| Q58283293 | Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery |
| Q37800538 | Impact of surgeon volume on outcomes of rectal cancer surgery: A systematic review and meta-analysis |
| Q35861966 | Impact of volume and specialization for cancer surgery |
| Q33267193 | Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 1: short-term outcome |
| Q81209594 | Laparoscopic vs open total mesorectal excision for rectal cancer: an evaluation of the mesorectum's macroscopic quality |
| Q45241659 | Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection |
| Q38133398 | MIS in the management of colon and rectal cancer: consensus meeting of the Colorectal Cancer Association of Canada |
| Q83945587 | Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team |
| Q39657726 | Managing rectal cancer: the Dutch experience |
| Q34986863 | Omental pedicle flaps following proctectomy: a systematic review |
| Q35904421 | Outcome of rectal cancer surgery in obese and nonobese patients: a meta-analysis |
| Q33417569 | Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial |
| Q35206264 | Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? |
| Q34771979 | Patterns of local recurrence in rectal cancer after a multidisciplinary approach |
| Q46195554 | Predicting quality of deceased donor kidneys: the harvesting surgeon as a prognostic factor? |
| Q47579865 | Quality of rectal cancer surgery and its relationship to surgeon and hospital caseload: a population-based study |
| Q37775911 | Rectal cancer surgery: volume-outcome analysis |
| Q36485457 | Rectal cancer: from outcomes of care to process of care. |
| Q36101559 | Rectal cancer: the role of radiotherapy |
| Q37057260 | Retrospective review of rectal cancer surgery in northern Alberta. |
| Q38137710 | Shifting focus in optical image-guided cancer therapy |
| Q44180743 | Sphincter preservation rates after radical resection for rectal cancer in the United States veteran population: opportunity for improvement in early disease |
| Q36583077 | Sphincter saving is the primary objective for local treatment of cancer of the lower rectum |
| Q80063964 | Stoma reversal: limitations and pitfalls |
| Q35106504 | Strategic impact of a new academic endocrine surgery program |
| Q85243848 | Surgeon and hospital-related risk factors in colorectal cancer surgery |
| Q44316515 | Surgeon-related factors and surgical quality in rectal cancer outcomes. Implications for specialization and organization |
| Q81085114 | Surgery for colorectal cancer in a low-volume unit: assessment of key issues in the achievement of acceptable clinical results |
| Q36021863 | Surgical management of locally recurrent rectal cancer |
| Q37167580 | Surgical margins and short-term results of laparoscopic total mesorectal excision for low rectal cancer |
| Q37779578 | Surgical specialization and training - its relation to clinical outcome for colorectal cancer surgery |
| Q50944057 | System-based factors influencing intraoperative decision-making in rectal cancer by surgeons: an international assessment. |
| Q33895569 | Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery |
| Q42726390 | Techniques for restoring bowel continuity and function after rectal cancer surgery |
| Q43900481 | The association between county-level surgeon density and esophageal and gastric cancer mortality |
| Q36970059 | The effect of hospital and surgeon volume on outcomes for rectal cancer surgery |
| Q46965192 | The number of analyzed lymph nodes - a prognostic factor in colorectal cancer |
| Q36632862 | The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review |
| Q35207073 | The role of the surgeon in quality cancer care |
| Q73289016 | The surgeon as a risk factor |
| Q37447002 | The surgeon's expertise-outcome relationship in gastric cancer surgery |
| Q34547677 | Total mesorectal excision: technical aspects |
| Q30883626 | Training and quality assurance for rectal cancer: 20 years of data is enough |
| Q52641186 | Transanal total mesorectal excision for rectal cancer: evaluation of the learning curve. |
| Q43057356 | Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. |
| Q37582434 | Use of Pre-Ablation Radioiodine-131 Scan to Assess the Impact of Surgical Volume and Specialisation following Thyroidectomy for Differentiated Thyroid Carcinoma |
| Q45061884 | Volume and outcome in rectal cancer surgery: the importance of quality management |
| Q36585319 | Volume of procedures and risk of recurrence after repair of groin hernia: national register study |
| Q53699321 | Volume-outcome relationship for colorectal cancer in primary care: a prospective cohort study. |
| Q38611705 | What can we learn from oncology surgical trials? |
| Q24201131 | Workload and surgeon´s specialty for outcome after colorectal cancer surgery |
| Q54678569 | [Radiotherapy-associated morbidity and mortality in rectal surgery]. |
| Q40479567 | [Study of in-patient hospital stay following total laryngectomy: multivariable retrospective analysis of a 442 total laryngectomies] |
| Q79268944 | [Surgical therapy of rectal carcinoma] |
Search more.